Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -11.45% is 7672% below its 5-year average of -0.15%, around the middle of its 5-year range (-39.35%–14.85%).
413.86% below its 12-month average of 3.65%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2025-12-31): 3.32%.
GROSS MARGIN
-11.45%
GROSS MARGIN AVG TTM
3.65%
GROSS MARGIN AVG 3Y
-1.26%
GROSS MARGIN AVG 5Y
-0.15%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-413.86%
CURRENT VS 3Y AVG
-811.03%
CURRENT VS 5Y AVG
-7671.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-127.67%
vs the sector median at left
Mobile-health Network Solutions Class A Ordinary Shares
Market Cap
$28295.00
Gross Margin
-11.45%
TTM Avg
3.65%
3Y Avg
-1.26%
5Y Avg
-0.15%
Market Cap
$6115.00
Gross Margin
N/A
TTM Avg
26.93%
3Y Avg
28.12%
5Y Avg
27.47%
Market Cap
$60942.00
Gross Margin
-60.46%
TTM Avg
-17.77%
3Y Avg
23.60%
5Y Avg
-269.73%
Market Cap
$71190.00
Gross Margin
-4864.71%
TTM Avg
-2432.36%
3Y Avg
-1195.54%
5Y Avg
-797.02%
Market Cap
$97282.00
Gross Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$108771.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$356454.00
Gross Margin
61.90%
TTM Avg
-388.16%
3Y Avg
-189.98%
5Y Avg
-127.92%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | $28295.00 | -11.45% | 3.65% | -1.26% | -0.15% |
| Zhongchao Inc. (ZCMD)vs › | $30997.00 | 42.47% | 49.33% | 46.84% | 51.88% |
| NewGenIvf Group Limited (NIVF)vs › | $6115.00 | N/A | 26.93% | 28.12% | 27.47% |
| Akanda Corp. (AKAN)vs › | $60942.00 | -60.46% | -17.77% | 23.60% | -269.73% |
| PRF Technologies Ltd. (PRFX)vs › | $71190.00 | -4864.71% | -2432.36% | -1195.54% | -797.02% |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108771.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | 73.71% | 56.22% | 66.21% | 71.99% |
| Virax Biolabs Group Limited (VRAX)vs › | $356454.00 | 61.90% | -388.16% | -189.98% | -127.92% |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | 0.00% | 0.00% | 2.16% | 0.42% |
Gross Margin
-11.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 3.32% |
| 2025-06-30 | -7.22% |
| 2024-12-31 | 14.85% |
| 2024-06-30 | -39.35% |
| 2023-12-31 | -7.74% |
| 2023-06-30 | 14.64% |
| 2022-12-31 | 12.70% |
| 2022-06-30 | 7.06% |
| 2021-12-30 | 10.71% |
| 2021-06-30 | -10.45% |
| 2020-12-30 | -10.45% |
